Thomas, Babatunde

Thomas, Babatunde was paid $199K by Medicaid between Jan 2018 and Jan 2023, across 14 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 93% of everything it billed.

33Billing provider infoTHOMAS, BABATUNDE
LEOMINSTER, MA 01453

33aNPI1568447480assigned 12/14/2005

33bProvider typeFamily Medicine Physician

28Total paid$199K

24GClaims2,671

24DCodes billed14

24AFirst – last monthJan 2018 – Jan 2023

Compared with peers

Next to other Family Medicine Physician providers in Massachusetts

Rank by total paid#91 of 744

Median peer was paid$10K

This provider vs. median19×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	787	$117K
2020	13	$0.00
2021	880	$38K
2022	977	$41K
2023	14	$2K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
T1015	A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive	93%	1,281	1,123	$184K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	3.6%	597	558	$7K
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	230	221	$2K
S9083	Global fee urgent care centers	<1%	14	14	$2K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	41	27	$2K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	20	13	$1K
0011A		<1%	16	16	$592.26
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	14	13	$281.52
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	35	35	$92.45
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	<1%	124	114	$77.77
90686		<1%	33	33	$40.00
83036	Hemoglobin; glycosylated (A1C)	<1%	26	26	$31.17

2 more codes

82962		<1%	191	$6.56
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	0%	49	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.